Back to today’s briefing

Story perspectives

FDA Panel Approves Pharmacy Peptide Production Amid Conflict-Ridden Appointments

7/24/2026

25 6 Full Breakdown

Summary

Story summary

FDA advisory panel voted to let pharmacies produce four peptide products, which are sold online as “research grade” items despite safety concerns.
Health Secretary Robert F. Kennedy Jr., who backs easing peptide restrictions, added eight new committee members, six of whom have sold peptide products.
Dr. Peter Lurie of the Center for Science in the Public Interest called the appointments an abuse of the advisory process.

1 of 1

Story summary

FDA advisory panel voted to let pharmacies produce four peptide products, which are sold online as “research grade” items despite safety concerns.
Health Secretary Robert F. Kennedy Jr., who backs easing peptide restrictions, added eight new committee members, six of whom have sold peptide products.
Dr. Peter Lurie of the Center for Science in the Public Interest called the appointments an abuse of the advisory process.